SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • September 28th, 2016 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 28th, 2016 Company Industry JurisdictionThis SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made and entered into as of September 27, 2016 (the “Amendment Closing Date”) by and among Bacterin International, Inc., a Nevada corporation (the “Borrower”), ROS acquisition offshore lp, a Cayman Islands Exempted Limited Partnership (“ROS”) and OrbiMed Royalty Opportunities II, LP, a Delaware limited partnership (“Royalty Opportunities”).